Market revenue in 2023 | USD 2.1 million |
Market revenue in 2030 | USD 3.5 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Mrna reprogramming |
Fastest growing segment | MRNA Reprogramming |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sendai Virus-based Reprogramming, MRNA Reprogramming, Episomal Reprogramming |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Bio-Techne Corp, ReproCELL, Lonza Group Ltd, FUJIFILM Holdings Corp, Astellas Pharma Inc, Allele Biotech, Alstem, STEMCELL Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell reprogramming market will help companies and investors design strategic landscapes.
Mrna reprogramming was the largest segment with a revenue share of 33.33% in 2023. Horizon Databook has segmented the Thailand cell reprogramming market based on sendai virus-based reprogramming, mrna reprogramming, episomal reprogramming covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of neurodegenerative diseases in Thailand is a key driver of cell reprogramming market. With an increase in the incidence of conditions such as neurologic diseases, there is a growing demand for innovative and effective treatments.
For instance, according to the UN, by 2050, Thailand is expected to witness a substantial demographic shift, with the elderly population projected to reach 20 million, constituting approximately 35.8% of the total population. This demographic transformation is expected to contribute to a substantial rise in dementia cases, aligning with the broader trend of an aging population.
Cell reprogramming offers a potential solution by harnessing the regenerative capabilities of iPSCs, which can be directed to differentiate into specific neural cell types, providing a customized approach for disease modeling, drug discovery, and potential cell replacement therapies.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand cell reprogramming market , including forecasts for subscribers. This country databook contains high-level insights into Thailand cell reprogramming market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account